Fate Therapeutics (FATE) Interest Coverage Ratio (QoQ) (2013 - 2019)
Fate Therapeutics (FATE) Interest Coverage Ratio (QoQ) (2013 - 2019) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Fate Therapeutics |
250.86 Mn |
250.86 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2019 |
28.52% |
| Sep 30, 2019 |
-12.60% |
| Jun 30, 2019 |
-19.27% |
| Mar 31, 2019 |
-29.67% |
| Dec 31, 2018 |
-0.06% |
| Sep 30, 2018 |
15.65% |
| Jun 30, 2018 |
-35.23% |
| Mar 31, 2018 |
-14.78% |
| Dec 31, 2017 |
-8.64% |
| Sep 30, 2017 |
39.40% |
| Jun 30, 2017 |
-20.43% |
| Mar 31, 2017 |
-61.13% |
| Dec 31, 2016 |
-6.77% |
| Sep 30, 2016 |
-18.42% |
| Jun 30, 2016 |
-16.22% |
| Mar 31, 2016 |
-23.00% |
| Dec 31, 2015 |
-22.04% |
| Sep 30, 2015 |
17.74% |
| Jun 30, 2015 |
2.32% |
| Mar 31, 2015 |
46.55% |
